These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36191295)

  • 1. Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy Volunteers.
    Djaelani YA; Giese T; Sommerer C; Czock D
    Ther Drug Monit; 2023 Feb; 45(1):87-94. PubMed ID: 36191295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Transpl Infect Dis; 2014 Jun; 16(3):379-86. PubMed ID: 24666466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic monitoring by residual gene expression of the nuclear factor of activated T cell-regulated genes in lung transplant recipients and its correlation with tacrolimus blood levels.
    Boada-Pérez M; Ruiz de Miguel V; Erro M; Ussetti P; Aguilar M; Castejón R; Rosado S; Escobar-Fornieles R; Revilla-López E; Bravo C; Sáez-Giménez B; Zapata-Ortega M; Villena-Ortiz Y; Vima-Bofarull J; Monforte V; Gómez-Ollés S
    Front Immunol; 2024; 15():1382459. PubMed ID: 38799459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients.
    Billing H; Breil T; Schmidt J; Tönshoff B; Schmitt CP; Giese T; Engelmann G
    Pediatr Transplant; 2012 Mar; 16(2):187-94. PubMed ID: 22360403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study.
    Sommerer C; Brunet M; Budde K; Millán O; Guirado Perich L; Glander P; Meuer S; Zeier M; Giese T
    Br J Clin Pharmacol; 2021 Oct; 87(10):3851-3862. PubMed ID: 33620734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Ann Transplant; 2014 Jan; 19():32-40. PubMed ID: 24457606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.
    Bremer S; Vethe NT; Skauby M; Kasbo M; Johansson ED; Midtvedt K; Bergan S
    Br J Clin Pharmacol; 2017 Nov; 83(11):2494-2502. PubMed ID: 28686294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.
    Millán O; Ruiz P; Fortuna V; Navasa M; Brunet M
    Liver Int; 2020 Apr; 40(4):931-946. PubMed ID: 31883422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients
.
    Keller F; Sommerer C; Giese T; Zeier M; Schröppel B
    Clin Nephrol; 2017 Feb; 87 (2017)(2):93-99. PubMed ID: 28025957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical Validation and Cross-Validation of an NFAT-Regulated Gene Expression Assay for Pharmacodynamic Monitoring of Therapy With Calcineurin Inhibitors.
    Abdel-Kahaar E; Giese T; Sommerer C; Rieger H; Shipkova M; Wieland E
    Ther Drug Monit; 2016 Dec; 38(6):711-716. PubMed ID: 27661400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomonitoring of nuclear factor of activated T cells-regulated gene expression: the first clinical trial in liver allograft recipients.
    Zahn A; Schott N; Hinz U; Stremmel W; Schmidt J; Ganten T; Gotthardt D; Meuer S; Zeier M; Giese T; Sommerer C
    Liver Transpl; 2011 Apr; 17(4):466-73. PubMed ID: 21445930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus.
    Maguire O; Tornatore KM; O'Loughlin KL; Venuto RC; Minderman H
    Cytometry A; 2013 Dec; 83(12):1096-104. PubMed ID: 24136923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia.
    Sommerer C; Zeier M; Czock D; Schnitzler P; Meuer S; Giese T
    Ther Drug Monit; 2011 Aug; 33(4):373-9. PubMed ID: 21743376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin Inhibitors.
    Sommerer C; Giese T
    Ther Drug Monit; 2016 Apr; 38 Suppl 1():S50-6. PubMed ID: 26418701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualizing calcineurin inhibitor therapy in renal transplantation--current limitations and perspectives.
    Press RR; de Fijter JW; Guchelaar HJ
    Curr Pharm Des; 2010; 16(2):176-86. PubMed ID: 20205663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older.
    Sommerer C; Schnitzler P; Meuer S; Zeier M; Giese T
    Ther Drug Monit; 2011 Dec; 33(6):694-8. PubMed ID: 22105585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
    Sommerer C; Zeier M; Meuer S; Giese T
    Transplantation; 2010 Jun; 89(11):1417-23. PubMed ID: 20463649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
    Sommerer C; Giese T; Schmidt J; Meuer S; Zeier M
    Transplantation; 2008 Jan; 85(1):15-21. PubMed ID: 18192906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients.
    Billing H; Giese T; Sommerer C; Zeier M; Feneberg R; Meuer S; Tönshoff B
    Pediatr Transplant; 2010 Nov; 14(7):844-51. PubMed ID: 20602720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.